GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenas BioPharma Inc (NAS:ZBIO) » Definitions » Other Current Payables

ZBIO (Zenas BioPharma) Other Current Payables : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Zenas BioPharma Other Current Payables?

Zenas BioPharma's Other Current Payables for the quarter that ended in Dec. 2024 was $0.00 Mil.

Zenas BioPharma's quarterly Other Current Payables stayed the same from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($0.00 Mil) but then increased from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($0.00 Mil).

Zenas BioPharma's annual Other Current Payables stayed the same from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil).


Zenas BioPharma Other Current Payables Historical Data

The historical data trend for Zenas BioPharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenas BioPharma Other Current Payables Chart

Zenas BioPharma Annual Data
Trend Dec22 Dec23 Dec24
Other Current Payables
- - -

Zenas BioPharma Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Current Payables Get a 7-Day Free Trial Premium Member Only - - - - -

Zenas BioPharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Zenas BioPharma Other Current Payables Related Terms

Thank you for viewing the detailed overview of Zenas BioPharma's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenas BioPharma Business Description

Traded in Other Exchanges
N/A
Address
852 Winter Street, Suite 250, Waltham, MA, USA, 02451
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.

Zenas BioPharma Headlines

From GuruFocus